Subsequent Events

6 Months Ended

Jun. 30, 2012

Subsequent Events

Subsequent Events

Note 5 — Subsequent Events

Public Stock Offering

On July 17, 2012, we filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) for a public offering of our common stock for proceeds of up to $28.75 million before related commissions and expenses.  We expect to complete the offering in the third quarter 2012 and use the net proceeds to fund our pivotal clinical trial and for general corporate purposes.

CE Mark

On July 23, 2012, we received CE Mark for our C-Pulse Heart Assist System.  We expect to commence a post-market clinical trial in select countries in Europe beginning in the second half of 2012.